Effect [qlco]    
virologic [ftcn]    
Response [orga]    
development [phsf]    
Hepatocellular carcinoma [neop]    
Hepatitis B [dsyn]    
Viral [ftcn]    
Cirrhotic [qlco]    
patient [podg]    
Comparison [acty]    
compensate [qlco]    
Decompensated [qlco]    
Cirrhosis [dsyn]    
Object [inpr]    
This [euka]    
studies [mnob]    
Aim [idcn]    
To [qlco]    
Evaluable [ftcn]    
Risk [qlco]    
development [phsf]    
Hepatocellular carcinoma [neop]    
Hepatic status [qlco]    
virologic [ftcn]    
Response [orga]    
Hepatitis B, Chronic [dsyn]    
patient [podg]    
Cirrhosis [dsyn]    
Concentrate [menp]    
treatment [ftcn]    
Associate [menp]    
Hepatocellular carcinoma [neop]    
development [phsf]    
Evaluable [ftcn]    
Method [inpr]    
% total [qnco]    
patient [podg]    
diagnose [fndg]    
Liver Cirrhosis [dsyn]    
TREAT [topp]    
month [tmco]    
followed [tmco]    
occurrence [ftcn]    
Hepatocellular carcinoma [neop]    
median [spco]    
Follow-up [fndg]    
Duration [tmco]    
month [tmco]    
patient [podg]    
Hepatocellular carcinoma [neop]    
month [tmco]    
Exclude [idcn]    
virologic [ftcn]    
Response [orga]    
Defined [cnce]    
Level [qlco]    
IU/mL [qnco]    
month [tmco]    
treatment [ftcn]    
Result [ftcn]    
% total [qnco]    
patient [podg]    
68 [inpr]    
compensate [qlco]    
Cirrhosis [dsyn]    
Remaining [qlco]    
patient [podg]    
31 [inpr]    
Decompensated [qlco]    
Cirrhosis [dsyn]    
>5 [qnco]    
year [tmco]    
Cumulative [qlco]    
Incidence [qnco]    
Hepatocellular carcinoma [neop]    
Regression Analysis [inpr]    
Identifiable [qlco]    
Following [tmco]    
Independence [idcn]    
Risk factor [qnco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Age [orga]    
year [tmco]    
Hazard Ratio [qnco]    
Confidence Interval [qnco]    
3/18 [fndg]    
Male [fndg]    
Sex [orgf]    
Hazard Ratio [qnco]    
Confidence Interval [qnco]    
1+ [qnco]    
High [qlco]    
Serum [bdsu]    
Level [qlco]    
month [tmco]    
Hazard Ratio [qnco]    
1+ [qnco]    
Confidence Interval [qnco]    
1+ [qnco]    
virologic [ftcn]    
Response [orga]    
month [tmco]    
Hazard Ratio [qnco]    
+2 [qnco]    
Confidence Interval [qnco]    
1+ [qnco]    
subgroup [virs]    
Analysis [lbpr]    
Show [inpr]    
virologic [ftcn]    
Response [orga]    
month [tmco]    
Significance [qnco]    
Risk factor [qnco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Decompensated [qlco]    
Cirrhosis [dsyn]    
Hazard Ratio [qnco]    
Confidence Interval [qnco]    
1+ [qnco]    
0.022" [qnco]    
Not [ftcn]    
With [qlco]    
compensate [qlco]    
Cirrhosis [dsyn]    
Conclusion [idcn]    
Antiviral [phsu]    
treatment [ftcn]    
Not [ftcn]    
Complete [qlco]    
Risk [qlco]    
Hepatocellular carcinoma [neop]    
patient [podg]    
Cirrhosis [dsyn]    
virologic [ftcn]    
Response [orga]    
Associated [qlco]    
low [qlco]    
Probabilities [qnco]    
patient [podg]    
Decompensated [qlco]    
Cirrhosis [dsyn]    
Hepatocellular carcinoma [neop]    
